.jpg)
Sir Peter John Ratcliffe, FRS, FMedSci (born 14 May 1954) is a British physician-scientist who is trained as a nephrologist.[1][2][3] He was a practising clinician at the John Radcliffe Hospital, Oxford and Nuffield Professor of Clinical Medicine and head of the Nuffield Department of Clinical Medicine at the University of Oxford from 2004 to 2016. He has been a Fellow of Magdalen College, Oxford since 2004. In 2016 he became Clinical Research Director at the Francis Crick Institute,[4] retaining a position at Oxford as a member of the Ludwig Institute of Cancer Research and director of the Target Discovery Institute, University of Oxford.[5]
Ratcliffe is best known for his work on cellular reactions to hypoxia, for which he shared the 2019 Nobel Prize in Physiology or Medicine with William Kaelin Jr. and Gregg L. Semenza.[6][7]
- ^ Peter Ratcliffe - Hypoxia Biology Laboratory - website of the Francis Crick Institute
- ^ Cite error: The named reference
naturewas invoked but never defined (see the help page). - ^ Sir Peter Ratcliffe - website of the Hellenic Society of Biochemistry and Molecular Biology
- ^ "Peter Ratcliffe | The Francis Crick Institute". The Francis Crick Institute. Retrieved 3 January 2018.
- ^ "Peter Ratcliffe". Crick. Retrieved 8 October 2019.
- ^ "The Nobel Prize in Physiology or Medicine 2019". NobelPrize.org. Retrieved 7 October 2019.
- ^ Kolata, Gina; Specia, Megan (7 October 2019). "Nobel Prize in Medicine Awarded for Research on How Cells Manage Oxygen". The New York Times. Retrieved 8 October 2019.